|

Pharmacological Agents Interacting With Methadone

Information on NAMA’s website is not
intended as medical advice for individual problems. 

 Appropriate medical professionals
should be consulted regarding addiction and addiction recovery.


 

Pharmacologic
Agents

Clinical
Signs
and Symptoms

Comments

Drugs That Decrease Methadone Levels

Rifampin, phenytoin, carbamazepine, butabarbital
sodium, mephobarbital, phenobarbital, secobarbital, ethanol (chronic),
disulfiram, urinary acidifiers, ascorbic acid

Withdrawal signs

Disulfiram may decrease methadone levels but not
significantly. Not clinically problematic.

Drugs That Increase Methadone Levels

Cimetidine, diazepam, ethanol (acute), fluvoxamine
maleate, ketoconazole, urinary alkalinizers

Increased sedation and other opiate effects

Cimetidine can be used in patients with low trough
methadone levels to prolong action (note: must consider cimetidine
effects on other concurrent medications).

Drugs With Levels Affected by Methadone

Desipramine (DMI), zidovudine (AZT)

Possible increased toxicity of DMI and AZT

Methadone descreases DMI and AZT metabolism; may
increase side effects. Close clinical monitoring needed.

Other Opioid and Analgesic Agents

Naltrexone, malmefene,maloxone, buprenorphine,*
butorphanol,* dezocine,* nalbuphine,* pentazocine,* tramadol

Withdrawal signs

 

 

*

Pain-relievers with opioid-antagonist activity.

Synthetic analgesic (not considered opioid
antagonist, but does decrease levels of opiates).

Data from Stine and Kosten,
Addiction Treatment Forum,
Kalvik et al, and Nillson et al.

This chart
courtesy of MedScape

 
The National Alliance Of Methadone Advocates

 

Similar Posts

  • About Webring

    Admin 06/30/2021

    Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Committee Chair John Finger Assistant to the Chair, Michael Garrett Co-chair, Alice Diorio Committee James DePasquale Becky Duarte Barbara Finger Carlos Franco Greg Keller Howard Lotsof Judith Ostergard Carmen Pearman Diane Seaman Joycelyn Woods NAMA Events and Activities Exhibition Booth Booth Manager: Greg Keller,…

  • NAMA Talk-1

    Admin 04/22/2021

    NAMA Talk Volumn 2, Number 2 March 15, 2000 Organizational News by Joycelyn Woods This will be a short column since there is a lot of Reading in this issue of NAMA Talk and we are busy, busy, busy with the AMTA Conference. Maureen Neville reports that the Patient Board had a meeting last week…

  • Executive Report-1

    Admin 10/14/2022

    HEROIN ADDICTION – HOW METHADONE WORKS Carmen Arlt, Director of Chemical Dependency & Addictions, Porter-Starke Services and Director, The MAG Indiana The Munster Times Mon, 01 Sep 2003 Porter Starke Services’ Chemical Dependency and Addictions Program has a clear understanding of the dynamics involved in heroin addiction. While we do not dispense methadone, we believe…

  • State Agencies & Regulation Information

    Admin 10/19/2021

      Alabama Division of Substance Abuse Services Home Page http://www.mh.state.al.us/services/sa/sa-main_html Alaska Division of Alcoholism and Drug Abuse Home Page http://health.hss.state.ak.us/dada/ Alaska Regulations http://www.touchngo.com/lglcntr/akstats/acc/title07chapter033.htm Arizona Bureau of Substance Abuse Treatment and Prevention Services Home Page http://health.state.az.us/ Index http://www.hs.state.az.us/bhs/index.htm Arkansas Division of Treatment Services Bureau of Alcohol and Drug Abuse Prevention Home Page http://www.healthyarkansas.com/ Arkansas Regulations http://www.healthyarkansas.com/index.html…

  • |

    Substance Abuse and Mental Health Services Administration (SAMHSA)

    Admin 06/11/2023

    Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT) Telephone (240) 276-2717 1Choke Cherry Road, Room 2-1065 Facsimile (240) 276-1630 Rockville, Maryland 20857 E-mail: [email protected] Division of Pharmacologic Therapies DPT C. Todd Rosendale, MA Public Health Advisor ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ FACSIMILE AInformation Memorandum@   This facsimile is intended only for the addressee…

  • CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)-2

    Admin 09/14/2022

     Responsible Medication Assisted Treatment (MAT) Advocacy First the ground rules! In every thing NAMA-R does the rights and dignity of the individual patient take precedence. It is never, ever, OK to violate that rule no matter how important the issue. NAMA-R has not and will never serve as an apologist for poor treatment. Everyone whether…